Ryszard Milczarek

Ryszard Milczarek

Auto-generated profile, based on publicly available information

Ryszard Milczarek

Department of Pharmaceutical Biochemistry, Medical University of Gdansk, Gdansk, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2010 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
RMRyszard Milczarek
Ryszard Milczarek
AHAnna Hallmann
Anna Hallmann
ESEwa Sokołowska
Ewa Sokołowska
KKKrystian Kaletha
Krystian Kaletha
JKJerzy Klimek
Jerzy Klimek

23 October 2017 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
ESEwa Sokolowska
Ewa Sokolowska
MPMalgorzata Presler
Malgorzata Presler
EGElzbieta Goyke
Elzbieta Goyke
RMRyszard Milczarek
Ryszard Milczarek
JSJulian Swierczynski
Julian Swierczynski
TŚTomasz Śledziński
Tomasz Śledziński
Background/aim: Pancreatic cancer is a disease with very poor prognosis, and none of currently available pharmacotherapies have proven to be efficient in this indication. The aim of this study was to analyze the expression of fatty acid synthase (FASN) gene as a potential therapeutic target in proliferating human pancreatic cancer cells (PANC-1), and verify if orlistat, originally developed as an anti-obesity drug, inhibits PANC-1 proliferation. Materials and Methods: The effects of orlistat on gene expression, lipogenesis, proliferation and apoptosis was studied in PANC-1 cell culture. Results: Expression of FASN increased during proliferation of PANC-1. Inhibition of FASN by orlistat resulted in a significant reduction of PANC-1 proliferation and enhanced apoptosis of these cells. Conclusion: This study showed, to our knowledge for the first time, that orlistat exhibits significant antitumor activity against PANC-1 cells. This implies that orlistat analogs with good oral bioavailability may find application in pharmacotherapy of pancreatic cancer.

1 March 2019 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
BKBarbara Kutryb-Zajac
Barbara Kutryb-Zajac
PMPaulina Mierzejewska
Paulina Mierzejewska
ESElzbieta Sucajtys-Szulc
Elzbieta Sucajtys-Szulc
ABAlicja Bulinska
Alicja Bulinska
MZMagdalena A. Zabielska
Magdalena A. Zabielska
RSRyszard T. Smolenski
Ryszard T. Smolenski

22 May 2019 in PeerJ
Verified
Journal Article
Open access
AHAnna Hallmann
Anna Hallmann
LKLucyna Konieczna
Lucyna Konieczna
JSJustyna Swiezak
Justyna Swiezak
RMRyszard Milczarek
Ryszard Milczarek
KSKa Sm
Ka Sm
In this study, we demonstrated the presence of the enzymatic complex able to perform aromatization (estrogen synthesis) in both, the microsomal and mitochondrial fractions of gills and gonads fromMytilus trossulus. Based on in vitro experiments, we highlighted the importance of temperature as the limiting factor of aromatisation efficiency (AE) in mussels. After testing range of temperatures (4–23 °C), the highest AE was found during incubation at 8 °C and pH 7.6 (41.66 pmol/h/mg protein in gills and 58.37 pmol/h/mg protein in gonads). The results were confirmed during field studies where the most efficient aromatisation occurred in bivalves collected in spring while the least effective in those collected in winter. During in vitro studies, AE turned out to be more intensive in female gonads than in male gonads. The process was also more intensive in mitochondrial fraction than in microsomal one (62.97 pmol/h/mg protein in male gills and 73.94 pmol/h/mg protein in female gonads). Enzymatic complex (aromatase-like enzyme) catalysing aromatisation in mussels was found to be insensitive to inhibitory effect of selective inhibitors of mammalian aromatase such as letrozole and anastrazole, suggesting its different structure from vertebrate aromatase. Further in vivo studies using13C-labeled steroids at 8 °C temperature window confirmed that bivalves are able to uptake testosterone and androstenedione from the ambient environment and metabolise them to estrone and 17β-estradiol thus confirming endogenous estrogen’ synthesis.

1 July 2000 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
RMRyszard Milczarek
Ryszard Milczarek
JKJerzy Klimek
Jerzy Klimek
LŹLeon Źelewski
Leon Źelewski

12 January 2018 in Molecular and Cellular Biochemistry
Verified
Journal Article
Open access
PDF file
ESElzbieta Sucajtys-Szulc Sucajtys-Szulc
Elzbieta Sucajtys-Szulc Sucajtys-Szulc
Alicja Dębska-ŚlizieńAlicja Dębska-Ślizień
Alicja Dębska-Ślizień
BRBoleslaw Rutkowski
Boleslaw Rutkowski
RMRyszard Milczarek
Ryszard Milczarek
IPIwona Pelikant-Malecka
Iwona Pelikant-Malecka
MSMarek Szolkiewicz
Marek Szolkiewicz
Inflammation related to chronic kidney disease (CKD) is an important clinical problem. We recently determined that hepatocyte nuclear factor 1α (HNF1α) was upregulated in the livers of chronic renal failure (CRF) rats—experimental model of CKD. Considering that the promoter region of gene encoding C-reactive protein (CRP) contains binding sites for HNF1α and that the loss-of-function mutation in the Hnfs1α leads to significant reduction in circulating CRP levels, we hypothesized that HNF1α can activate the Crp in CRF rats. Here, we found coordinated upregulation of genes encoding CRP, interleukin-6 (IL-6), HNF1α, and HNF4α in the livers and white adipose tissue (WAT) of CRF rats, as compared to the pair-fed and control animals. This was accompanied by elevated serum levels of CRP and IL-6. CRP and HNFs’ mRNA levels correlated positively with CRP and HNFs’ protein levels in the liver and WAT. Similar upregulation of the Crp, Il-6, and Hnfs in the liver and WAT and increased serum CRP and IL-6 concentrations were found in lipopolysaccharide (LPS)-induced systemic inflammation in rats. Moreover, silencing HNF1α in HepG2 cells by small interfering RNA led to decrease in CRP mRNA levels. Our results suggests that (a) HNFs act in concert with IL-6 in the upregulation of CRP production by the liver and WAT, leading to an increase in circulating CRP concentration in CRF rats and (b) CRF-related inflammation plays an important role in the upregulation of genes that encode HNFs and CRP in the liver and WAT of CRF rats.